Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia

Anesthesia and Analgesia

Volumn 110, Issue 5, 2010, Pages 1457-1460

  Kanai, Akifumi ^a   Okamoto, Takashi ^a   Suzuki, Kaoruko ^a   Niki, Yuriko ^a   Okamoto, Hirotsugu ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; EYE DROPS; LIDOCAINE; MEXILETINE; NEUROTROPIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; PROSTAGLANDIN E1; SODIUM CHLORIDE;

ADULT; AGED; ANALGESIA; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EYE PAIN; FEMALE; FOREHEAD; HEART RATE; HUMAN; INJECTION SITE IRRITATION; MALE; OPHTHALMIC POSTHERPETIC NEURALGIA; OUTCOME ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; VISUAL ANALOG SCALE;

EID: 77951708683     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181d5adaf     Document Type: Article

References (20)

1. Gazewood JD, Meadows S, Halverson L. Clinical inquiries. What is the prognosis of postherpetic neuralgia? J Fam Pract 2003;52:496-497
2. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005;2:628-644
3. Stow PJ, Glynn CJ, Minor B. EMLA cream in the treatment of post-herpetic neuralgia. Efficacy and pharmacokinetic profile. Pain 1989;39:301-305
4. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995;37:246-253
5. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
6. Wallace MS. Calcium and sodium channel antagonists for the treatment of pain. Clin J Pain 2000;16:S80-5
7. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61:310-316
8. Harding SP. Management of ophthalmic zoster. J Med Virol 1993;suppl 1:97-101
9. Harding SP, Lipton JR, Wells JC. Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement. Br J Ophthalmol 1987;71:353-358
10. Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005;101:1738-1749
11. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996;66:69-77
12. Bellucci R, Morselli S, Pucci V, Zordan R, Magnolfi G. Intraocular penetration of topical lidocaine 4%. J Cataract Refract Surg 1999;25:642-647
13. Choi YK, Liu J. The use of 5% lidocaine for prolonged analgesia in chronic pain patients: a new technique. Reg Anesth Pain Med 1998;23:96-100
14. Dias MP, Newton DJ, McLeod GA, Khan F, Belch JJ. The inhibitory effects of local anaesthetics on the vascular flare responses to bradykinin and substance P in human skin. Anaesthesia 2008;63:151-155
15. Newton DJ, McLeod GA, Khan F, Belch JJ. Mechanisms influencing the vasoactive effects of lidocaine in human skin. Anaesthesia 2007;62:146-150
16. De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 1996;65:45-51
17. Tan JH, Burton RL. Does preservative-free lignocaine 1% for hydrodissection reduce pain during phacoemulsification? J Cataract Refract Surg 2000;26:733-735
18. Shaikh S, Ta CN. Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician 2002;66:1723-1730
19. Hirata M, Sakaguchi M, Mochida C, Sotozono C, Kageyama K, Kuroda Y, Hirose M. Lidocaine inhibits tyrosine kinase activity of the epidermal growth factor receptor and suppresses proliferation of corneal epithelial cells. Anesthesiology 2004; 100:1206-1210
20. Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989;39:129-144